4-Deep Brain Reconstruction
The 4-DBR consortium aims to develop a transplantable 4D reconstructed brain to regenerate neurological disorders, integrating advanced bioprinting and stimulation technologies for effective therapy.
Projectdetails
Introduction
The 4-Deep Brain Reconstruction, 4-DBR consortium aims at generating a brand-new technological approach to regenerate brain affections that occur in neurological disorders. With 180 million affected people and an economic burden of 798 billion euros/year, Europe needs a radical leap into the future.
Challenges in Brain Regeneration
The complexity of the human brain has condemned every past attempt at regeneration because incomplete technologies did not allow for a full recapitulation of the brain properties. Any one of them missing jeopardized the functionality of the whole.
There can't be any incremental solution for brain damage; the technology must be all-in.
Project Focus
4-DBR will focus on developing an implantable 4D reconstructed brain able to recapitulate all brain properties. This includes:
- A complex architecture of neuronal cells integrated into a complete blood circuitry.
- An integrated opto-stimulator to induce correct specification and integration of neurons.
Technological Integration
4-DBR integrates six technological leaders from complementary fields who will unite to develop the components of reconstructed brains:
- Laser-assisted bioprinting of pre-differentiated neurons with their native decellularized brain matrix.
- Extrusion bioprinting of the vascular system.
- In vitro blood-brain barrier reconstruction.
- A tissue-integrated wireless-controlled stimulating optoelectrical chip.
These four components will then be combined into a transplantable reconstructed brain that will be tested in a small animal model of Huntington’s disease.
Timeline and Vision
While a first prototype will be delivered in 36 months, the vision unifying 4-DBR expands way further.
Dissemination and Exploitation Plan
Therefore, the project will put into action a strong dissemination and exploitation plan:
- Horizontally, 4-DBR will ensure the uptake of the generated methods to strengthen Europe’s technological actors.
- Vertically, 4-DBR will thrust the reconstructed brain approach up in the development ladder to potentially generate, in a 10-year span, a therapy to change the lives of many patients.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.987.775 |
Totale projectbegroting | € 2.987.775 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-8-2025 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYERpenvoerder
- POIETIS
- VERIGRAFT AB
- DANMARKS TEKNISKE UNIVERSITET
- OSPEDALE SAN RAFFAELE SRL
- UNIVERSITAT DE BARCELONA
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Dynamic Spatio-Temporal Modulation of Light by Phononic ArchitecturesDynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements. | EIC Pathfinder | € 2.552.277 | 2022 | Details |
Emerging technologies for crystal-based gamma-ray light sourcesTECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology. | EIC Pathfinder | € 2.643.187 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures
Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.
Emerging technologies for crystal-based gamma-ray light sources
TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Engineering human cortical brain organoid’s connections to restore brain functionsThis project aims to restore functional neuronal networks in cortical brain lesions using 3D bioprinted human-specific hydrogels and cortical brain organoids for innovative therapeutic solutions. | ERC STG | € 1.500.000 | 2024 | Details |
4D Brain-Targeting Nanomedicines for Treating NeurodegenerationThis project aims to develop advanced 4D-brain-targeting nanoparticles using nanotechnology to effectively deliver treatments for neurodegenerative diseases across the blood-brain barrier. | ERC COG | € 2.000.000 | 2023 | Details |
A Digitally-Enabled Electroconductive Patient-Specific Stimulation Implant for Spinal Cord InjuryThis project aims to develop a patient-specific 3D-printed neuromodulation implant to enhance neuron regrowth and restore function in spinal cord injury patients through targeted electrical stimulation. | ERC POC | € 150.000 | 2025 | Details |
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitationCorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Engineering human cortical brain organoid’s connections to restore brain functions
This project aims to restore functional neuronal networks in cortical brain lesions using 3D bioprinted human-specific hydrogels and cortical brain organoids for innovative therapeutic solutions.
4D Brain-Targeting Nanomedicines for Treating Neurodegeneration
This project aims to develop advanced 4D-brain-targeting nanoparticles using nanotechnology to effectively deliver treatments for neurodegenerative diseases across the blood-brain barrier.
A Digitally-Enabled Electroconductive Patient-Specific Stimulation Implant for Spinal Cord Injury
This project aims to develop a patient-specific 3D-printed neuromodulation implant to enhance neuron regrowth and restore function in spinal cord injury patients through targeted electrical stimulation.
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation
CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.